Assenagon Asset Management S.A. Takes Position in Enovis Co. (NYSE:ENOV)
Assenagon Asset Management S.A. bought a new position in Enovis Co. (NYSE:ENOV – Free Report) during the 4th quarter, ...
Enovis names new president for international surgical unit
WILMINGTON, DE - Enovis (NYSE: ENOV), a prominent medical technology company with a market capitalization of $2.54 billion, has announced the appointment of Davide Visentin as the new President of ...
Zacks Industry Outlook Enovis, Omnicell and Phreesia
Chicago, IL – January 24, 2025 – Today, Zacks Equity Research Equity are Enovis ENOV, Omnicell OMCL and Phreesia PHR. Link: ...
MassDevice9d
Enovis appoints new president of International Surgical business
Enovis (NYSE: ENOV) announced today that it appointed Davide Visentin as the new president of its International Surgical ...
Enovis’s Strategic Growth and Optimistic 2025 Outlook Drive Buy Rating by Vik Chopra
In a report released yesterday, Vik Chopra from Wells Fargo reiterated a Buy rating on Enovis (ENOV – Research Report), with a price target of ...
Morningstar9d
Enovis™ Announces Leadership Change to International Surgical Business
Wilmington, DE, Jan. 17, 2025 (GLOBE NEWSWIRE) -- Enovis™, a global medical technology innovator headquartered in the United States, announced recently that Davide Visentin will succeed Dr ...
Becker's Spine Review9d
Enovis taps president of international surgical business
Enovis has named Davide Visentin as its new president of the international surgical business, according to a Jan. 17 report from Mass Device. Mr. Visentin will succeed Benjamin Reinmann, MD, beginning ...
bovnews12d
What Factors Have Led to Enovis Corp (ENOV) Stock Trading -30.26% Below Its 52-Week High?
On Monday, Enovis Corp (ENOV) stock saw a modest uptick, ending the day at $45.35 which represents a slight increase of $0.58 or 1.30% from the prior close of $44.77. The stock opened at $44.43 and ...
Business Insider20d
Enovis to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Wilmington, DE, Jan. 06, 2025 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today announced that its management team will meet with ...
Nasdaq9d
Lobbying Update: $40,000 of ENOVIS lobbying was just disclosed
$40,000 of ENOVIS lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on issues like: "Medicare DME Competitive Bidding reforms and ...
Oak Thistle LLC Purchases Shares of 7,385 Enovis Co. (NYSE:ENOV)
Oak Thistle LLC acquired a new position in shares of Enovis Co. (NYSE:ENOV – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission ...
news.stocktradersdaily15d
Trading (ENOV) With Integrated Risk Controls
Check the time stamp on this data. Updated AI-Generated Signals for Enovis Corporation (ENOV) available here: ENOV. Type a ...